DSIP is a short peptide claimed to promote deeper, more restorative sleep without acting like a conventional sedative.
What DSIP does and why that matters
DSIP is a nine-amino-acid peptide named after a proposed link to deep, slow-wave sleep. The hoped-for practical effect is deeper or more restorative sleep without acting like a conventional sedative. Researchers have not identified a specific receptor or settled biological role, and the evidence does not show that DSIP reliably improves insomnia or how rested people feel. [1,2]
Function evidence: Historical sleep research; normal role remains unknown
What better sleep would need to look like
A useful sleep treatment should do more than change a sleep-stage recording. A person would want to fall asleep more reliably, wake less often, sleep for an appropriate length of time and feel more rested or functional the next day. Historical DSIP studies used different populations, methods and outcomes, and they did not establish that pattern of benefit. The name 'delta sleep-inducing peptide' sounds more certain than the evidence is. Researchers still have not settled its receptor, normal role or predictable effect in people. [1,2]
What supports this description: Mixed historical sleep research; reliable patient benefit not demonstrated
DSIP Dosing status
Dose: No consumer dose is established or recommended here. | Frequency: No routine treatment schedule established. | Cycle: No validated consumer cycle. | Route: No routine patient route established.
Preparation: No patient reconstitution recipe. Trial preparation is not a recommendation..
Research on delta sleep-inducing peptide (DSIP) is old, small and varied. It has not established DSIP as a treatment for insomnia, shown a reliable time to effect or produced a sound injection protocol for patients. [1,2]
DSIP Effects
Sleep outcomes. Historical studies used varied populations, methods, and outcomes. They do not support a predictable claim that DSIP increases deep sleep or fixes insomnia in routine use. [1]
DSIP Side Effects
Evidence and product uncertainty. Modern dose-finding, interaction, and long-term safety evidence is lacking. FDA also identifies safety and characterization concerns for compounded DSIP. [2]
Frequently Asked Questions About DSIP
Does DSIP reliably induce sleep?
The name is not a clinical guarantee. Small historical studies are inconsistent and do not establish reliable treatment of insomnia. [1]
What is the best DSIP dose?
No routine dose, route, cycle, or stacking protocol is established by adequate modern trials. [1,2]
Evidence
Old, small and inconsistent human literature. Research on delta sleep-inducing peptide (DSIP) is old, small and varied. It has not established DSIP as a treatment for insomnia, shown a reliable time to effect or produced a sound injection protocol for patients. [1,2]
Kovalzon VM, Strekalova TV. Delta sleep-inducing peptide (DSIP): a still unresolved riddle J Neurochem, 2006. PMID 16539679
U.S. Food and Drug Administration Certain Bulk Drug Substances for Use in Compounding that May Present Significant Safety Risks: DSIP , . Source
Storage
Educational evidence summary. Approval applies only to the named product and indication; compounded, investigational, and research-market products are different categories.
◇An FDA-approved label or a patient-specific prescription from a licensed pharmacy
◇The active ingredient, strength, dosage form, concentration, lot, and dispensing instructions
◇Identity or purity tests only support the tests performed; they do not prove sterility, endotoxin safety, dose accuracy, stability, or clinical suitability
◇A “research use only” vial is not a patient medicine
